Scope
Description
service for non-invasive prenatal diagnosis (NIPD) by relative haplotype dosage (RHDO) for diseases DMD and SMA
Contract 1. KAPA Hyperchoice Max BWC
Supplier
Contract value
- £12,622.88 excluding VAT
- £15,147.46 including VAT
Below the relevant threshold
Date signed
1 March 2025
Contract dates
- 1 April 2025 to 1 March 2026
- 11 months, 1 day
Main procurement category
Goods
CPV classifications
- 33696200 - Blood-testing reagents
Procedure
Procedure type
Below threshold - without competition
Supplier
Roche Diagnostics
Charles Avenue, Burgess Hill
West Sussex
RH15 9RY
United Kingdom
Email: diaukiecomms@roche.com
Region: UKJ28 - West Sussex (North East)
Small or medium-sized enterprise (SME): Yes
Voluntary, community or social enterprise (VCSE): Yes
Contract 1. KAPA Hyperchoice Max BWC
Contracting authority
Birmingham Women's and Children's NHS Foundation Trust
- Public Procurement Organisation Number: PNXM-2771-CPCW
Steelhouse Lane
Birmingham
B4 6NH
United Kingdom
Region: UKG31 - Birmingham
Organisation type: Public authority - central government
Other organisation
These organisations are carrying out the procurement, or part of it, on behalf of the contracting authorities.
University Hospitals Birmingham NHS Foundation Trust
Summary of their role in this procurement: University Hospitals Birmingham NHS Foundation Trust host the Birmingham and Solihull (BSOL) Procurement Collaborative, a shared procurement service acting on behalf of multiple Trusts within the Birmingham and Solihull Integrated Care System.
- Public Procurement Organisation Number: PWVL-6877-BXXV
Mindelsohn Way
Birmingham
B15 2WB
United Kingdom
Region: UKG31 - Birmingham
Contact organisation
Contact Birmingham Women's and Children's NHS Foundation Trust for any enquiries.